Tag: Gefapixant

An estimated 5-10% of adults globally suffer from chronic cough, defined as a cough lasting longer than eight weeks [1.6.6]. For those with this persistent condition, a key question has emerged: **is gefapixant available on prescription** as a potential treatment?

Chronic cough, defined as a cough lasting more than eight weeks, affects an estimated 5-10% of adults globally. For this patient population, the search for a new pill for coughing has shifted from general suppressants to targeted therapies addressing specific neurological pathways involved in the cough reflex.